Braal, C. Louwrens http://orcid.org/0000-0003-3600-9851
Kleijburg, Anne
Jager, Agnes
Koolen, Stijn L. W.
Mathijssen, Ron H. J.
Corro Ramos, Isaac
Wetzelaer, Pim
Uyl-de Groot, Carin A.
Funding for this research was provided by:
Erasmus Medisch Centrum (grant number 2017-17108)
Article History
Accepted: 16 December 2021
First Online: 12 January 2022
Declarations
:
: This work was supported by an MRACE grant of the Erasmus Medical Center, the Netherlands (grant number 2017-17108).
: None declared (CLB, AK, AJ, SK, RM, ICR, PW, CUdG).
: The study was approved by the Local Ethics Committee (Erasmus MC, Rotterdam; MEC 17-548) and was registered at the Dutch Trial Registry (NL6918).
: Written informed consent was obtained from all patients participating in the TOTAM trial.
: Not applicable.
: The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: LB collected and assembled the data and led the writing of the manuscript. LB and AK led the development of the cost effectiveness model. All authors participated in data analysis and interpretation, creation of figures and tables, and writing and editing of the manuscript.